About Belmar Pharma Solutions
Belmar Pharma Solutions is a company based in Golden (United States) founded in 2019 was acquired by MedEquity in May 2019. Belmar Pharma Solutions has completed 1 acquisition, including Women's International Pharmacy. Belmar Pharma Solutions offers products and services including Hormone Pellets, Low Dose Naltrexone, Thyroid Hormones, and Testosterone Cypionate. Belmar Pharma Solutions operates in a competitive market with competitors including UMC Utrecht, AngelEye Health, Pasteur Institute, Pediatrix Medical Group and Fakeeh Care Group, among others.
- Headquarter Golden, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Webster Equity Partners
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
MedEquity
(May 23, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Belmar Pharma Solutions
Belmar Pharma Solutions offers a comprehensive portfolio of products and services, including Hormone Pellets, Low Dose Naltrexone, Thyroid Hormones, and Testosterone Cypionate.
Customized pellets for hormone replacement therapy.
Treatment for chronic conditions like autoimmune diseases.
Compounded options for thyroid health management.
Injectable for hormone balance in men's health.
People of Belmar Pharma Solutions
Unlock access to complete
Unlock access to complete
Funding Insights of Belmar Pharma Solutions
Detailed funding history for Belmar Pharma Solutions
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Belmar Pharma Solutions
Belmar Pharma Solutions has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Webster Equity Partners and MedEquity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare-focused private equity investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Acquisitions are targeted by MedEquity as a private equity firm.
|
Locked | Locked | Locked |
Investor details for Belmar Pharma Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Belmar Pharma Solutions
Belmar Pharma Solutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Women's International Pharmacy.
Investment portfolio details for Belmar Pharma Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Compounded medications for women's health needs are provided internationally.
|
Locked | Locked | 1985 | Locked |
Complete acquisition details for Belmar Pharma Solutions
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Belmar Pharma Solutions
Detailed financials for Belmar Pharma Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Belmar Pharma Solutions Comparisons
Peer comparison for Belmar Pharma Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Belmar Pharma Solutions
Belmar Pharma Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as UMC Utrecht, AngelEye Health, Pasteur Institute, Pediatrix Medical Group and Fakeeh Care Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare education and training services are provided to professionals.
|
|
| Locked | Locked | Locked |
Provider of NICU cameras, communication, feed management, and education services for hospitals
|
|
| Locked | Locked | Locked |
Provider of healthcare education services
|
|
| Locked | Locked | Locked |
Continuing medical education training and courses are provided to professionals.
|
|
| Locked | Locked | Locked |
A leading healthcare provider in Saudi Arabia, expanding into Dubai's healthcare and medical education markets.
|
|
| Locked | Locked | Locked |
Provider of medical education, research, and patient care. This organization offers MD and graduate degree programs, conducts cutting-edge biomedical research, and delivers exemplary patient care through affiliated hospitals. Faculty are engaged in clinical practice and scientific discovery, translating breakthroughs into improved treatments and prevention strategies. The institution fosters a culture of mentorship and supports global health initiatives. Educational programs are highly selective and include international partnerships. Research focuses on advancing knowledge in areas such as cancer and cardiovascular disease.
|
Detailed competitors of Belmar Pharma Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Belmar Pharma Solutions
Complete news archive for Belmar Pharma Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Belmar Pharma Solutions
Belmar Pharma Solutions was founded in 2019.
Belmar Pharma Solutions is headquartered in Golden, United States. It is registered at Golden, Colorado, United States.
Dave Hill is the current CEO of Belmar Pharma Solutions.
Belmar Pharma Solutions was established in 2019 in Golden, United States, focusing on the pharmaceutical sector. Compounded medications are prepared and distributed, alongside educational programs and consultation services for healthcare needs. Operations are centered on personalized pharmaceutical solutions, with the companys domain listed as belmarpharmasolutions.com. Leadership is provided by CEO Dave Hill, supporting service delivery in the region.
Belmar Pharma Solutions's top competitors include Weill Cornell Medicine, Sure Med Compliance and UMC Utrecht.
Belmar Pharma Solutions offers Hormone Pellets, Low Dose Naltrexone, Thyroid Hormones, and Testosterone Cypionate.
Belmar Pharma Solutions has made 1 acquisition, including Women's International Pharmacy.
Belmar Pharma Solutions has 2 investors. Key investors include Webster Equity Partners, and MedEquity.